Pediatric Pulmonary Vascular Disease

Morbidity in children after fetoscopic endoluminal tracheal occlusion for severe congenital diaphragmatic hernia: Results from a multidisciplinary clinic

Shelby R. Sferra, Melanie K. Nies, Jena L. Miller, Alejandro V. Garcia, Erica I. Hodgman, Annalise B. Penikis, Abigail J. Engwall-Gill, Vera Joanna Burton, Jessica L. Rice, Peter J. Mogayzel, Ahmet A. Baschat, Shaun M. KunisakiJohns Hopkins University School of Medicine. United States Journal of Pediatric SurgeryJ Pediatr Surg 2023; 58: 14-19DOI: 10.1016/j.jpedsurg.2022.09.042 AbstractBackground: Although fetoscopic endoluminal […]

Morbidity in children after fetoscopic endoluminal tracheal occlusion for severe congenital diaphragmatic hernia: Results from a multidisciplinary clinic Read More »

Long-term outcomes of congenital diaphragmatic hernia: A single institution experience

Claire D. Gerall, Latoya A. Stewart, Jessica Price, Sandra Kabagambe, Shelby R. Sferra, Rebecca Hernan, Julie Khlevner, Usha S. Krishnan, Alive De, Gudrun Aspelund, Vincent P. DuronColumbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Morgan Stanley Children’s Hospital.United States Journal of Pediatric SurgeryJ Pediatr Surg 2022; 57: 563-569DOI: 10.1016/j.jpedsurg.2021.06.007 AbstractBackground/purpose: As survival rates for patients

Long-term outcomes of congenital diaphragmatic hernia: A single institution experience Read More »

Association between Genotype, Presentation, and Outcome in Childhood Idiopathic and Hereditary Pulmonary Arterial Hypertension

Zhuoyuan Xu, Hongsheng Zhang, Chen Zhang, Qiangqiang Li, Hong GuBeijing Anzhen Hospital and Capital Medical University, No. 2.China Journal of Clinical MedicineJ Clin Med 2022; 11: DOI: 10.3390/jcm11247331 AbstractBackground: Paediatric-onset idiopathic/hereditary pulmonary arterial hypertension (IPAH/HPAH) is partially linked to genetic factors that may also affect treatment response and outcome. The relation between clinical characteristics and pathogenicity of

Association between Genotype, Presentation, and Outcome in Childhood Idiopathic and Hereditary Pulmonary Arterial Hypertension Read More »

An Adolescent Patient With Idiopathic Pulmonary Arterial Hypertension Weaned Off Intravenous Epoprostenol Following Treatment With Selexipag: A Case Report

Ayako Chida-Nagai, Takao Tsujioka, Daisuke Sasaki, Gaku Izumi, Hirokuni Yamazawa, Atsuhito TakedaHokkaido University Hospital.Japan Frontiers in PediatricsFront Pediatr 2022; DOI: 10.3389/fped.2022.909595 AbstractIdiopathic pulmonary arterial hypertension (PAH) is a rare, progressive disease affecting the pulmonary arteries. Epoprostenol, a synthetic prostaglandin analog, is the most potent pharmacological treatment modality used in patients with PAH. However, it requires continuous

An Adolescent Patient With Idiopathic Pulmonary Arterial Hypertension Weaned Off Intravenous Epoprostenol Following Treatment With Selexipag: A Case Report Read More »

Clinical impact of subcutaneous treprostinil in trisomy 21 patient with pulmonary arterial hypertension associated with CHD

Ryusuke Numata, Kiyohiro Takigiku, Kouta TakeiNagano Children’s HospitalJapan Cardiology in the YoungCardiol Young 2022; DOI: 10.1017/S1047951121005096 AbstractSubcutaneous treprostinil is commonly used to improve idiopathic pulmonary arterial hypertension in children. However, its effectiveness has not been reported in trisomy 21. We report the case of 9-year-old boy in trisomy 21 with CHD-pulmonary artery hypertension after surgical correction

Clinical impact of subcutaneous treprostinil in trisomy 21 patient with pulmonary arterial hypertension associated with CHD Read More »

A Study on the Molecular Mechanism of High Altitude Heart Disease in Children

Qu-Zhen Tashi, Sang-Bu Tsering, Na-Ni Zhou, Yi Zhang, Yu-Juan Huang, Jia Jia, Ting-Jun LiShigatse Peopel’s Hospital. Fujungenetics Technologies Inc. Children’s Hospital of Shanghai.China Pharmacogenomics and Personalized MedicinePharmgenomica Pers Med 2022; 15: 721-731DOI: 10.2147/PGPM.S356206 AbstractObjective: High altitude heart disease (HAHD) is a common pediatric disease in high altitude areas. It usually occurs in people who have lived for

A Study on the Molecular Mechanism of High Altitude Heart Disease in Children Read More »

Seven-day in vivo testing of a novel, low-resistance, pumpless pediatric artificial lung for long-term support

Brian P. Fallon, Alex J. Thompson, Aaron R. Prater, Skylar Buchan, Trevor Alberts, Mark Hoenerhoff, Alvaro Rojas-Pena, Robert H. Bartlett, Ronald B. HirschlUniversity of Michigan Medical School and Michigan Medicine.United States Journal of Pediatric SurgeryJ Pediatr Surg 2022; 57: 614-623DOI: 10.1016/j.jpedsurg.2022.07.006 AbstractIntroduction: For children with end-stage lung disease that cannot wean from extracorporeal life support (ECLS), a

Seven-day in vivo testing of a novel, low-resistance, pumpless pediatric artificial lung for long-term support Read More »

Quantitative cardiopulmonary magnetic resonance imaging in neonatal congenital diaphragmatic hernia

Jean A. Tkach, Nara S. Higano, Michael D. Taylor, Ryan A. Moore, Monir Hossain, Guixia Huang, David R. Spielberg, Sean B. Fain, Paul S. Kingma, Jason C. WoodsCincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine. Texas Children’s Hospital. University of Iowa. University of Wisconsin.United States Pediatric RadiologyPediatr Radiol 2022; 52: 2306-2318DOI: 10.1007/s00247-022-05384-w

Quantitative cardiopulmonary magnetic resonance imaging in neonatal congenital diaphragmatic hernia Read More »

Eisenmenger Syndrome Among Children with Unrepaired Congenital Heart Defects in Yunnan, China

Fangqi Guo, Ruey-Kang Chang, Robert C. DetranoUniversity of California Irvine. Harbor-UCLA Medical Center. China California Heart Watch.United States and China Pediatric CardiologyPediatr Cardiol 2022; 43: 1848-1856DOI: 10.1007/s00246-022-02922-z AbstractEisenmenger syndrome is a life-threatening complication of congenital heart defects (CHD). Since Eisenmenger syndrome among children of repaired CHD is rare, very few studies have had the necessary data

Eisenmenger Syndrome Among Children with Unrepaired Congenital Heart Defects in Yunnan, China Read More »

Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series

Shawn A. Mahmud, Danielle R. Bullock, Colleen K. Correll, Patricia M. Hobday, Mona M. Riskalla, Richard K. Vehe, Bryce A. BinstadtUniversity of Minnesota. United States Pediatric RheumatologyPediatr Rheumatol 2022; 20: DOI: 10.1186/s12969-022-00732-4 AbstractBackground: Non-criteria antiphospholipid antibodies (NC-aPL) are a relatively undefined subgroup of antiphospholipid antibodies (aPL). Knowledge about NC-aPL in adults is limited and even less is

Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series Read More »

Scroll to Top